Skip to main content

This platform is for Australian healthcare professionals only

Video Library

Fabrazyme reconstitution and administration video

Prof Namdar - Electrocardiographic Abnormalities & Arrhythmia in Cardiomyopathies

Dr Leslie Burnett - Interpreting a Genomics Report

Dr Rick Steeds - Introduction to Fabry Disease

Laura Yeates - Preparing your patient for genetic testing

Dr Ashwin Roy - Fabry & Lifestyle (Case Study 4)

Dr Rick Steeds - Fabry & Families (Case Study 1)

Dr Kozor - Role of Cardiac MRI in Fabry Disease

Assoc Prof Thomas - High Risk Population Screening and Multidisciplinary Clinic

Dr Pieroni - Challenges in Cardiology during the COVID-19 Pandemic

Prof Namdar - Diagnosis of Hypertrophic Cardiomyopathies Based on ECG Parameters

Prof Namdar - Differentiation Between Hypertrophic Cardiomyopathy & Athlete's Heart (ECG parameters)

Prof Namdar - Differentiation Between Infiltrative Cardiomyopathies Based on ECG Parameters

Dr Tchan & Prof Thomas - Fabry Disease - The Hypertrophic Cardiomyopathy Imposter

Dr Alison McLean - Clinician Guide to Ordering a Genetic Test

Prof John A Sayer - Family, Phenotype, Fabry (Case Study 1)

Dr Ashwin Roy - Fabry, The Heart & Beyond (Case Study 3)

Dr Kozor - What is the Significance of LGE in Fabry Disease?

Prof Namdar - Management of Conduction Abnormalities and Arrhythmia in Fabry Cardiomyopathy

Prof John A Sayer - Beware of Autopilot CKD (Case Study 2)

Dr Rick Steeds - Fabry & the Passage of Time (Case Study 2)

Dr Kozor - How Can Papillary Muscles Differentiate Hypertrophic Hearts in Fabry Disease?

Dr Kozor - What Can CMR Tell Us About Patients with Fabry Disease?

A/Prof Jodie Ingles - Genetic Testing and Counselling for Inherited Cardiovascular Diseases

Prof John A Sayer - Atypical presentation of Fabry Females (Case Study 4)

Prof Chris Semsarian AM - Clinical Utility of Genetic Testing in Cardiac Disorders

Prof John A Sayer - Beware of pre-existing diagnostics labels (Case Study 3)

Dr Kozor - What Can T1 Mapping Tell Us About Cardiac Structure and Function in Fabry Disease?

Dr Pieroni - Watch Out for the Red Flags for Fabry Disease to Avoid Missing the Diagnosis

Fabrazyme (agalsidase beta) PBS Information:

This product is not listed on the PBS. This product is listed on the Life Saving Drugs Program.

Please review full Product Information before prescribing, available here or by calling 1800 818 806.

YOU WILL NOW BE LEAVING THE SITE

You are now leaving campus.sanofi/au

Campus Sanofi Australia does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

Campus Sanofi Australia makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Campus Sanofi Australia necessarily endorse such website and/or database.
The information the reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in Australia.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.